Akbank places 420-day discounted bond with qualified investors
The bank disclosed a TRY 173751000 nominal issuance, with investor-account transfers scheduled for October 12 and repayment due in December 2027.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 45 of 89
The bank disclosed a TRY 173751000 nominal issuance, with investor-account transfers scheduled for October 12 and repayment due in December 2027.
Stocks
A supplementary protocol provides for a capacity increase at the Kalecik plant, taking Aksa Enerji’s installed capacity in Northern Cyprus to 223 MW.
Stocks
Kaleseramik says it has attached a report covering the full use of funds from its paid capital increase, but the filing text gives no breakdown.
Stocks
Halk Yatırım said its liquidity-provider account recorded no transactions in Emlak Konut Damlakent certificates from September 28 to October 9.
Stocks
The company transferred all its SNT shares to Sonat Bayram, while the sale’s profit or loss is still being calculated.
Stocks
The company expects about two weeks of review and negotiations before final agreements are signed and regulatory applications are filed.
Stocks
Hayri Ögelman Madencilik’s board approved a capital increase and sales of existing shares, and appointed Vakıf Yatırım to manage the offering.
Stocks
Bulls Girişim reported selling TGS Dış Ticaret shares on Oct. 9, lowering its disclosed ownership and voting-rights percentages.
Stocks
An extraordinary meeting extended the capital ceiling for five years and authorized the board to raise capital within that limit.
Stocks
The company’s October 9 purchase brought its shares held under the program to 729,775, or 0.0973% of its capital.
Stocks
Işıklar Holding bought 150,000 Çemaş shares for TL 471,000, lifting its reported stake from 11.50% to 11.52%.
Stocks
The company says it bought 5,000 shares on Oct. 9, bringing repurchases under its three-month program to 225,000.
Stocks
The companies plan tools for bank activity, direct-debit processes and POS reporting, but disclosed no financial terms or launch schedule.
Stocks
The company reported selling its remaining Oncosem shares on Borsa Istanbul, recording a gain and ending its investment in the company.
Stocks
The company says it bought 5,000 B-group shares on October 9, bringing its total repurchases under the program to 92,500.
Stocks
The company said it acquired its own shares from Oct. 5 to Oct. 9 under a program managed by SEB Pank.
Stocks
Jim Cramer’s attention to FirstCash’s lending arm coincides with positive analyst views and a wide spread in community value estimates.
Stocks
The exchange operator renewed its exclusive index-options agreement and outlined plans for KPI-linked binary contracts, pending regulatory approval.
Stocks
The holding’s subsidiary acquired the stake through a cash-funded capital increase, with the company expecting the investment to lift turnover.
Stocks
The 20-year agreement calls for 890 megawatts of new nuclear capacity, with the first reactor upgrade expected by 2028.
Stocks
Gilead’s core HIV sales are growing, but acquisitions have made reported earnings harder to interpret and raised the stakes for future growth.
Stocks
The shares gained about 42% in a year, while older drug sales declined and newer medicines face pressure to sustain growth.
Stocks
The regulator approved CASA’s proposed capital-clause change, but ministry permissions and a shareholder vote remain before the amendment can take effect.
Stocks
Record AI-server sales and a larger bond offering have supported Dell’s surge, while valuation leaves less room for execution setbacks.
Stocks